We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

Fund managers haven’t disclosed any holdings of SGNT yet.

SGNT Hedge Fund Activity: Q3 2016 in Review

0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2016, worth a combined $0 — down 100% from $486M a quarter earlier.

Sellers outnumbered buyers: 128 funds closed out of SGNT and 0 opened new positions — a net loss of 128 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vivo Capital, exiting entirely with an estimated $97.3M sold.

  • 0 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2016, down from 128 in Q2 2016.
  • Funds reported $0 of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2016, down 100% quarter-over-quarter.
  • 0 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2016 and 128 closed out, a net change of -128 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2016 was Vivo Capital, an estimated $97.3M sold.

Based on aggregated 13F filings for Q3 2016.